Legal Opinion
Meijer, Inc. v. Abbott Laboratories
District Court, N.D. California
Decided April 11, 2008No. C 07-5985 CW, C 07-6010 CW, C 07-6118 CW, C 07-5470 CW, C 07-5702 CW, C 07-6120 CWPublishedCited by 4 opinions
1Opinion of the Court
ORDER DENYING ABBOTT’S MOTION TO DISMISS
(DOCKET NOS. 19, 23, 38, 24, 29, 44, 46, AND 18)
AND DENYING ABBOTT’S MOTION TO TRANSFER
(DOCKET NO. 19)
CLAUDIA WILKEN, District Judge.
Defendant Abbott Labs moves to dismiss the complaint in each of these related actions, arguing that Plaintiffs’ claims for monopolization and attempted monopolization of the market for boosted protease inhibitors are foreclosed by the recent Ninth Circuit case, Cascade Health Solutions v. PeaceHealth, 515 F.3d 883 (9th Cir.2008). Abbott moves separately to dismiss GlaxoSmithKline’s (GSK) claims in the SmithKline Beecham…
2Cases cited24 opinions
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Stewart Organization, Inc. v. Ricoh Corp.Supreme Court of the United States · 1988
- MedImmune, Inc. v. Genentech, Inc.Supreme Court of the United States · 2007
- Jones v. GNC Franchising, Inc.Court of Appeals for the Ninth Circuit · 2000
- Brooke Group Ltd. v. Brown & Williamson Tobacco Corp.Supreme Court of the United States · 1993
19 more not listed; retrieve them via the Exa API.
3Cited by4 opinions
- John Doe 1 v. Abbott LaboratoriesCourt of Appeals for the Ninth Circuit · 2009
- In re Keurig Green Mountain Single-Serve Coffee Antitrust Litig.District Court, S.D. Illinois · 2019
- John Doe v. Abbott LabortoriesCourt of Appeals for the Ninth Circuit · 2009
- Tokarski v. Med-Data IncDistrict Court, W.D. Washington · 2022